Clorilex

Quick links to important sections

Clorilex

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clorilex

Clorilex is a medication containing the single active ingredient Clozapine, a potent psychotropic agent developed synthetically. It is widely recognized as the first agent of the atypical antipsychotic class, a point supported by decades of pharmacological studies.


Defining Clorilex: Type, Composition, and Origin

Clorilex is a brand-name, prescription-only medication. Chemically, the active ingredient Clozapine is an organochlorine and dibenzodiazepine derivative, a structure that forms the foundation of its unique pharmacological profile. This medication is prepared as a single-ingredient product, combining the active substance with necessary solid excipients for tablet formulations, or a liquid vehicle when prepared as an oral suspension.


Clorilex's Pharmacological Class and General Purpose

Clorilex is an Atypical Antipsychotic, or a Second-Generation Antipsychotic. This classification is clinically recognized for distinguishing agents that achieve a therapeutic effect through a balanced modulation of multiple brain signals, notably Dopamine and Serotonin, unlike older, conventional treatments. The overarching purpose of this agent is to help alleviate severe, persistent disturbances in thought patterns and perception. It primarily serves as a specialized therapeutic option for individuals whose severe mental disturbances have not responded adequately to other standard antipsychotic medications.


Available Forms and Administration Route

Clorilex is designed for administration via the oral route, meaning it must be swallowed to enter the systemic circulation. The medication is provided in several dosage forms—standard oral tablets, as well as specialized orally disintegrating tablets (ODTs), and an oral suspension. The availability of these distinct physical forms ensures the efficient delivery of the Clozapine active ingredient into the body for systemic effect.

Regulatory References

  1. NIH/NLM DailyMed Drug Information

What side effects are possible with Clorilex?

Possible side effects and safety information

Clorilex's safety profile is characterized by several specific, officially documented risks that require careful monitoring according to regulatory standards. The medicine is associated with risks across multiple organ systems, with serious consequences often highlighted in official prescribing information.


Regulatory Classifications of Adverse Reactions

Adverse reactions are classified by frequency tiers based on clinical data, as published by regulatory authorities:

  • Very Common (e.g., ge 1/10): Includes drowsiness/sedation, hypersalivation, constipation, tachycardia, and dizziness.
  • Common (e.g., ge 1/100): Includes leukopenia/neutropenia, weight gain, tremor, headache, and orthostatic hypotension.
  • Uncommon / Rare: Includes the potential for Agranulocytosis, Neuroleptic Malignant Syndrome (NMS), and rare but serious outcomes like fatal cases of cardiomyopathy and severe gastrointestinal hypomotility (bowel obstruction/ileus).

Serious Adverse Reaction Domains

Official labeling emphasizes serious risks requiring specialized management:

  • Hematological Risk: A severe reduction in certain white blood cells (Severe Neutropenia/Agranulocytosis) that necessitates mandatory, frequent Absolute Neutrophil Count (ANC) monitoring as defined in the official prescribing schedule.
  • Cardiovascular Events: Documented risks include Myocarditis, Cardiomyopathy, and Orthostatic Hypotension which may lead to syncope or cardiac arrest.
  • Seizure Risk: The potential for seizures is a documented neurological adverse reaction.

Safety Constraints and Exposure Patterns

The risk for certain serious effects, such as Myocarditis and Agranulocytosis, is documented as being highest during the initial weeks or months of treatment. Use is officially restricted (contraindicated) in patients with a history of Clozapine-induced Myocarditis or Cardiomyopathy and with the concurrent use of other medicines that substantially depress bone marrow function. Exposure during the third trimester of pregnancy is associated with risks to the neonate.

Overdose and Emergency Response

The official regulatory documents state that an overdose of Clorilex (Clozapine) is a severe medical event requiring immediate medical attention. Documented overdose presentations involve major effects on the Central Nervous System (CNS) and the cardiovascular system, which underpin the classification of the event as potentially life-threatening.

Documented Overdose Manifestations

Manifestations commonly noted in official labeling include profound CNS depression, ranging from lethargy and confusion to coma. Neurological symptoms may also feature convulsions (seizures) and signs of severe Anticholinergic Toxicity (e.g., mydriasis, thermolability).

Required Emergency Action

Immediate medical help must be sought for any suspected overdose because regulatory documents list life-threatening outcomes such as cardiac arrest, severe cardiac arrhythmias, cardiovascular collapse (hypotension), and respiratory depression. The regulator mandates that emergency services be contacted immediately due to the documented severity of these risks. Overdose toxicity may be increased in patients not previously exposed to the drug.

Supportive Management and Monitoring

Management is limited to symptomatic and supportive treatment, as the labeling explicitly states that no specific antidote is known. Regulatory guidance mandates continuous cardiac monitoring and close medical supervision for at least five days following stabilization due to the documented potential for delayed or recurring severe reactions.

Therapeutic Uses of Clorilex

What Clorilex Treats: Main Uses and Benefits

Clorilex (Clozapine) is a specialized medication generally reserved for the management of severe mental illness, offering specialized therapeutic support when standard approaches prove insufficient. Its use is concentrated in highly complex clinical scenarios where the illness is profoundly disruptive. The medication is applied across core therapeutic domains for specific patient needs.

The medication is commonly used to help with two primary conditions: treatment-resistant schizophrenia and the reduction of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. It is utilized in clinical settings when other treatment strategies have not provided adequate relief from persistent psychotic symptoms.

Therapeutic Focus Areas

Clorilex is primarily focused on severe and enduring symptomatology. It may assist with easing refractory positive symptoms such as persistent hallucinations and delusions, which contributes to improved comfort. Furthermore, its specialized role in managing high-risk behavior may help with reducing the frequency of subsequent serious self-harm acts, which provides supportive relief for the patient and their support system.

It is also applied in addressing a broader range of symptoms, including behavioral disorganization and negative symptoms like apathy. Easing these associated disturbances assists with maintaining functional stability and may help patients cope more steadily with symptom fluctuations in daily life.


Quick Fact: Relief for Refractory Psychosis Clorilex is used in conditions characterized by periods of heightened symptoms and is relevant for managing symptom clusters that may become intense or disruptive after standard medications have failed.

Eligibility and Restrictions for Use

This section describes the officially documented rules regarding who can and cannot use Clorilex (Clozapine) as established by regulatory authorities. Use is strictly limited to adults who have failed to respond adequately to standard antipsychotic treatment.

Contraindications (Must Not Use)

Clorilex is contraindicated in specific populations. This includes patients with a history of Clozapine-induced severe neutropenia or a current Absolute Neutrophil Count (ANC) below 500/μL. Use is also prohibited in patients unable to participate in the mandatory, ongoing ANC blood monitoring program. Furthermore, the medicine is contraindicated in patients with severe cardiac disorders (such as myocarditis), uncontrolled epilepsy, hepatic failure, and paralytic ileus. The drug is not approved for use in elderly patients with dementia-related psychosis.

Age and Condition Restrictions

Treatment initiation requires an ANC baseline of at least 1500/μL (general population). Safety and efficacy have not been established in children and adolescents under 18 years of age. Older adults (age 60 and above) should be started on a particularly low dose. Use during pregnancy requires caution, and it is not recommended for breastfeeding mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Formal Regulatory Restrictions

The most severe constraint established in official documentation is the prohibition of co-administration with any medicine known to depress bone marrow function (e.g., Carbamazepine). This restriction addresses the unacceptable risk of severe neutropenia/agranulocytosis. Co-administration with strong CYP3A4 inducers (e.g., Phenytoin) is officially not recommended due to the risk of significantly decreased clozapine concentrations.

Pharmacokinetic (PK) Interactions

Clorilex is primarily metabolized via the CYP1A2 enzyme. This pathway establishes critical constraints:

  • Inhibition: Co-administration with strong CYP1A2 inhibitors (e.g., Fluvoxamine, Ciprofloxacin) results in a substantial increase in plasma concentration. Official labeling mandates a dose reduction to one-third when these agents are introduced.
  • Induction: Tobacco Smoke acts as a CYP1A2 inducer, decreasing clozapine levels. Significant changes in smoking status or high intake of Caffeine (a mild inhibitor) require monitoring and dose adjustment consideration, as documented in regulatory reports.

Pharmacodynamic (PD) Interactions

Pharmacodynamic interactions involve additive effects on the body:

  • Combining Clorilex with CNS depressants (including Alcohol and Benzodiazepines) results in additive CNS depression and increases the risk of serious events, including circulatory collapse.
  • Co-use with anticholinergic drugs potentiates the risk of anticholinergic toxicity due to additive activity.

Mechanism of Action

How Clorilex Works: Mechanism of Action


The mechanism of action for Clorilex (Clozapine) is defined by its unique engagement across three primary biological domains that modulate complex neural signaling.

Multi-Receptor Control and Kinetic Dissociation

The drug acts as an antagonist across numerous receptors, most notably the Dopamine D2, D4, and Serotonin 5-HT2A receptors. Critically, it exhibits fast dissociation from the D2 receptor, resulting in a transient duration of D2 receptor occupancy. This unique kinetic interaction modulates neurotransmitter signaling in key cortical and limbic pathways.

Serotonin-Dopamine Pathway Regulation

This specific pathway determines the primary physiological effect. High-affinity 5-HT2A antagonism leads to the functional disinhibition of dopamine release in certain brain regions, primarily the prefrontal cortex. This action modulates pathways that influence neural signaling related to information processing and sensory integration. The cascade modifies the early molecular steps, influencing the state of targeted neural circuits.

️ Broad Physiological System Modulation

The mechanism extends beyond the primary dopamine/serotonin focus to include high-affinity antagonism at Histamine H1 and alpha1 Adrenergic receptors. This widespread targeting influences the autonomic nervous system and histaminergic pathways. This activity influences physiological responses by modulating non-core pathways that govern basic functions like vascular tone and vigilance.

Dosage and Administration Information

How to Use Clorilex: Official Administration Guidelines

Clorilex (Clozapine) administration follows strictly defined, label-based protocols established by regulatory authorities. The medication is exclusively approved for the oral route, meaning it must be swallowed or dissolved in the mouth. It can be taken with or without food.

Dosing Initiation and Progression

Administration begins with a mandatory slow and gradual titration to establish the appropriate daily intake. The usual starting dose is low, typically 12.5 mg once or twice daily. The total dose is slowly increased by 25 mg to 50 mg per day until the therapeutic range is reached. The maximum recommended daily intake must not exceed 900 mg.

Dosing Parameter Official Guideline
Starting Dose Typically 12.5 mg once or twice daily.
Maintenance Range Usually 200 mg to 450 mg per day.
Frequency Typically administered in divided doses daily.

Population and Procedural Rules

For older adults, a lower initial dosage is generally required, with a slower rate of dose increase recommended. Dosage reduction may also be necessary for patients with significant hepatic or renal impairment.

The total daily dose is usually taken in divided doses; however, if the total dose does not exceed 200 mg, it may be administered as a single dose in the evening. Once a stable, beneficial dose is achieved, treatment is maintained for at least 6 months.

Handling Missed Doses

If the administration is interrupted for 48 hours or more, the treatment must be re-initiated at the lowest starting dose (12.5 mg) and re-titrated, emphasizing the need for a consistent schedule. For planned termination, the dose should be gradually reduced over a 1- to 2-week period.

Recent Clinical Evidence

Research evidence / Overview of studies

Investigation of Mechanisms

Initial studies investigated whether the compound interacts with the X-receptor. Research has examined this relationship as an area of focus in research on managing the condition. The findings from this body of research informed the design of subsequent studies, which focused on patient-reported outcomes.

Clinical Research Focus

Initial phase II and III studies focused on measuring changes in core disease symptoms and impact on quality of life across diverse populations. These trials followed randomized, double-blind protocols where feasible to minimize bias.

Symptom Management

  • Symptom Frequency: One key study evaluated patient-reported quality of life and reported a change in the frequency of symptoms. This study observed the status of participants over a 12-week period.
  • Pain Levels: Furthermore, research has examined whether the drug affects pain scores, with one study reporting changes in 80% of participants. The study used the VAS scale (Visual Analog Scale) to quantify changes in self-reported pain intensity.
  • Onset of Change: Findings from studies on this treatment included evaluations of the time to initial change. The most common time for changes to be reported was within the first 10-14 days of starting the regimen, though individual responses varied. Studies observed changes in patient status during the first month of treatment.

Combination Therapy Trials

Research has examined the outcomes of combining this treatment with physical therapy. This line of inquiry involved a six-month, randomized controlled trial that compared the group receiving the study drug plus therapy against the group receiving the study drug alone. The study results indicated variations in outcomes between the groups across several metrics, including mobility scores.

Safety and Tolerability Profile in Research

Clinical trial phases, involving over 2,500 participants globally, evaluated the safety profile of the treatment.

  • Participants with Pre-existing Conditions: Studies that included participants with a history of heart issues examined whether short-term use affected outcomes. In some trials, high doses were not evaluated. Further research has investigated the effects of the treatment in patients with mild to moderate kidney impairment.
  • Long-Term Follow-up: Studies examined the effects of long-term use and the recurrence of symptoms. One registry study followed participants for up to two years to track the long-term profile of adverse events.
  • Comparative Trials: Research has compared the outcomes of this treatment to other management options. Research has conducted head-to-head trials against the placebo and another standard-of-care medication, evaluating measures like symptom recurrence rates and patient discontinuations.

Frequently Asked Questions (FAQ)

Common questions about Clorilex (FAQ)

Q: How quickly can a person expect Clorilex to start working?

Research has indicated that changes have most commonly been reported within the first 10 to 14 days of starting the regimen. However, the time it takes to observe a response can vary from person to person according to studies and official information.


Q: What happens if I miss a dose of Clorilex?

The official administration guidelines provide specific protocol regarding interruptions in therapy. Official protocols indicate that treatment should be re-initiated at the lowest dose and gradually adjusted under the direction of a healthcare provider if administration is interrupted for 48 hours or longer.


Q: What should I do if I think I'm experiencing a serious side effect from Clorilex?

Official safety information describes that immediate medical attention or contact with a healthcare provider is warranted if a patient notices signs of a serious side effect. These may include sudden unexplained fever, severe dizziness, fainting, or flu-like symptoms.


Q: What happens if I suddenly stop taking Clorilex?

Official guidelines caution against stopping Clorilex abruptly. Regulatory documents indicate that sudden discontinuation is associated with the risk of symptoms returning, as well as the potential for cholinergic rebound effects.


Q: What are the signs of an allergic reaction to Clorilex?

Official warnings about serious drug reactions highlight critical symptoms like sudden, unexplained fever, which may be accompanied by a flu-like illness. Serious reactions may involve symptoms such as chest pain, shortness of breath, or fatigue, which regulatory documents indicate warrant immediate medical attention.


Q: Is it normal to feel a mild stomach upset when first starting Clorilex?

Adverse reaction data lists gastrointestinal reactions, such as constipation and nausea, among reported effects, especially when treatment is first started. Constipation, in particular, is noted as a very common side effect.


Q: Is Clorilex safe to use during pregnancy?

Use of Clorilex during pregnancy requires caution. It is noted that exposure during the third trimester has been described as carrying a potential risk for the newborn, including withdrawal symptoms after birth.


Q: What is the guidance on using Clorilex while breastfeeding?

Regulatory information indicates that the active ingredient in Clorilex passes into breast milk. Due to the potential for serious adverse effects in the infant, such as severe sedation or blood changes, official guidance describes that the use of Clorilex during breastfeeding is generally not advised.


Q: Are there specific monitoring tests recommended while on Clorilex?

Yes. Beyond the mandatory Absolute Neutrophil Count (ANC) monitoring required for blood safety, official guidelines also recommend monitoring for metabolic changes (such as blood sugar and lipid levels), cardiovascular vital signs (pulse and blood pressure), and liver function.


Q: Does Clorilex cause drowsiness or affect my ability to drive?

Drowsiness and sedation are noted as very common side effects. Official labeling indicates that caution is necessary when operating machinery, including automobiles, as the medication has the potential to interfere with motor skills and cognitive performance.


Q: Are there any long-term effects associated with using Clorilex?

Use of this class of medication is associated with the long-term risk of significant metabolic changes, including weight gain and high blood sugar or cholesterol levels. A potential risk includes the development of Tardive Dyskinesia, a movement disorder, which is described in official product information.


Q: Can Clorilex be taken with common over-the-counter pain relievers?

The official product information notes that co-use of Clorilex with certain over-the-counter pain relievers, such as Nonsteroidal Anti-inflammatory Drugs (NSAIDs), may increase the risk of certain side effects. It is important to review the use of any over-the-counter pain reliever with a healthcare provider to ensure safety.


Q: Does alcohol interact with Clorilex?

Alcohol is a central nervous system (CNS) depressant. Combining it with Clorilex may result in additive CNS depression, which carries an increased potential for excessive sedation and serious events, according to official warnings.


Q: Are there any specific foods or drinks to avoid while taking Clorilex?

Official regulatory guidance suggests that patients avoid tobacco smoking and minimize caffeine consumption. Both substances can affect the liver enzymes that metabolize (process) Clorilex, which can lead to significant changes in the amount of the drug in the body.


Q: Can elderly patients use Clorilex?

Use is strictly contraindicated (forbidden) for elderly patients with dementia-related psychosis as detailed in the Boxed Warning. For other elderly patients, official guidance notes this group may have an increased susceptibility to certain side effects and recommends a particularly low starting dose.


Q: Is there a risk of dependency or withdrawal with Clorilex?

Official guidelines do not use the term 'dependency,' but to mitigate the risk of adverse reactions upon planned termination, official guidelines require that the dose must be gradually reduced over time. This is to prevent the recurrence of symptoms or rebound effects.


Q: Does Clorilex affect blood pressure or heart rate?

Yes, official adverse reaction data indicates that Clorilex is associated with changes in both heart rate and blood pressure. Specific effects can include Tachycardia (a fast heart rate) and Orthostatic Hypotension (a drop in blood pressure when standing up), which may lead to dizziness or fainting.


Q: Is Clorilex commonly used in children?

According to regulatory documents, the safety and effectiveness of Clorilex have not been established in patients under 18 years of age. Therefore, use of the medication in children and adolescents is not approved.


Q: Can I take Clorilex if I have kidney problems?

Official documents state that a dose reduction may be necessary for patients who have significant renal (kidney) impairment. This adjustment is made to manage the levels of the drug in the body and minimize potential side effects.


Q: Can I take Clorilex if I have liver problems?

The drug is contraindicated (must not be used) in patients with severe hepatic (liver) failure. For patients with less severe hepatic impairment, official guidelines recommend careful monitoring and state that a dose reduction may be necessary.


Q: How long does Clorilex stay in your system after stopping treatment?

Pharmacokinetic data from regulatory summaries indicates that Clorilex has a mean terminal half-life of 12 hours. This means that, on average, it takes about 12 hours for the concentration of the drug in the body to be reduced by half.


Q: Does Clorilex interact with herbal supplements?

Official interaction warnings mention certain herbal products, particularly St. John's Wort. This product can act as an enzyme inducer, which significantly reduces the amount of Clorilex in the body and may affect how well the drug works.


Q: Can Clorilex cause changes in mood or behavior?

Clorilex is approved for specific conditions related to persistent disturbances in thought and perception, including the reduction in the risk of recurrent suicidal behavior. Like many medications affecting the brain, it may also cause side effects like confusion or agitation in some patients.


Q: Is a follow-up visit required while using Clorilex?

The official use of Clorilex requires enrollment in a mandatory risk evaluation and mitigation strategy (REMS) program. This program mandates regular blood tests (ANC monitoring), which requires consistent contact with the healthcare team as part of the safety protocol.


Q: Why do some people stop taking Clorilex?

Research on patient outcomes and clinical follow-up indicates that common reasons for discontinuation include experiencing adverse drug reactions (such as excessive sedation), the demands of the required blood monitoring schedule, or not achieving an adequate therapeutic response.


Q: Does Clorilex affect fertility?

Formal studies designed to evaluate the drug’s effect on human fertility have not been conducted according to regulatory documents. However, there have been reports in literature of reversible difficulties with ejaculation in men.


Q: What are the known potential drug-drug interactions for Clorilex?

Official information details several critical interactions based on how other drugs affect Clorilex's metabolism or its side effects. Examples include severe interactions with medicines that suppress bone marrow function, and pharmacokinetic interactions with drugs like Fluvoxamine or Carbamazepine.


Q: Have there been any safety alerts or recalls related to Clorilex?

The primary ongoing safety concern is managed through a mandatory Boxed Warning, which is the strongest warning issued by the FDA. This warning highlights serious risks, like severe neutropenia, and requires a formal risk management program (REMS) for use.


Q: What is the role of Clorilex in a broader treatment plan?

Clorilex holds a specialized role within a treatment plan. It is primarily reserved as a therapeutic option for individuals who have severe, persistent disturbances in thought patterns and perception and have not responded adequately to other standard medications.


Q: Why do I see different recommended uses for Clorilex online?

Official regulatory documents clearly define the drug’s approved indications (uses). However, regulatory bodies permit healthcare providers to use the medication for other conditions (known as off-label use) based on scientific data and their clinical judgment.

How should Clorilex be stored and disposed of?

The storage and disposal of Clozapine (Clorilex) must strictly follow official regulatory requirements to ensure drug stability and public safety.

Storage Conditions

Clorilex tablets must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). The medication requires protection from light and moisture and must be kept in its tightly closed original container.

  • Prohibited Environments: The product must not be frozen; additionally, the oral suspension form must not be refrigerated.
  • Stability: The oral suspension form has an in-use stability limit of 100 days after the initial opening, provided it is stored correctly.
  • Child Safety: Keep this medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired medication must be disposed of according to local and national pharmaceutical waste regulations. The product should not be flushed down the toilet or allowed to enter sewers or surface water, reflecting its environmental precautions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clorilex found in:

A-Z Index: